Search results for "Vomiting"

showing 10 items of 127 documents

Single-dose Palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving mode…

2011

PURPOSE: The control of nausea and vomiting induced by chemotherapy is paramount for overall treatment success in cancer patients. Antiemetic therapy during chemotherapy in lymphoma patients generally consists of anti-serotoninergic drugs and dexamethasone. The aim of this trial was to evaluate the efficacy of a single dose of palonosetron, a second-generation serotonin type 3 (5-HT(3)) receptor antagonist, in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy (MEC) containing steroids. METHODS: Patients received a single intravenous bolus of palonosetron (0.25 mg) before administration of chemotherapy. Complete response (CR) defined as no vomiting …

MaleQuinuclidinesmedicine.medical_treatmentCINVCHOPGastroenterologyDexamethasoneSettore MED/15 - Malattie Del SangueAntineoplastic Combined Chemotherapy ProtocolsSerotonin 5-HT3 Receptor AntagonistsProspective StudiesAged 80 and overLymphoma Non-HodgkinPalonosetronNauseaMiddle AgedEmesisPalonosetronTreatment OutcomeOncologyAnesthesiaCHOP CINV Emesis Nausea NHL PalonosetronVomitingFemaleOriginal Articlemedicine.symptomCHOP-CINV; emesis; nausea; NHL; Palonosetronmedicine.drugAdultmedicine.medical_specialtyVomitingNauseamedicine.drug_classNHLYoung AdultInternal medicinemedicineHumansAntiemeticGlucocorticoidsAgedChemotherapybusiness.industryIsoquinolinesmedicine.diseaseNon-Hodgkin's lymphomaAntiemeticsbusinessCHOPChemotherapy-induced nausea and vomiting
researchProduct

Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability a…

2010

The aim of this study was to investigate the cathodal iontophoresis of dexamethasone sodium phosphate (DEX-P) in vitro and in vivo and to determine the feasibility of delivering therapeutic amounts of the drug for the treatment of chemotherapy-induced emesis. Stability studies, performed to investigate the susceptibility of the phosphate ester linkage to hydrolysis, confirmed that conversion of DEX-P to dexamethasone (DEX) upon exposure to samples of human, porcine and rat dermis for 7 h was limited (82.2+/-0.4%, 72.5+/-4.8% and 78.6+/-6.0% remained intact) and did not point to any major inter-species differences. Iontophoretic transport of DEX-P across dermatomed porcine skin (0.75 mm thic…

MaleTime FactorsVomitingSwineSkin AbsorptionPharmaceutical ScienceAntineoplastic AgentsPharmacologyAdministration CutaneousHigh-performance liquid chromatographyDexamethasoneGlucocorticoids/administration & dosage/pharmacokineticsDexamethasone Sodium PhosphatePharmacokineticsDrug StabilitySpecies SpecificityIn vivoAnimalsHumansSkin/metabolismVomiting/chemically induced/prevention & controlRats WistarGlucocorticoidsTransdermalSkinddc:615IontophoresisDose-Response Relationship DrugChemistryHydrolysisGeneral MedicineAntineoplastic Agents/adverse effectsPermeationIontophoresisRatsDose–response relationshipDexamethasone/administration & dosage/analogs & derivatives/pharmacokineticsBiotechnologyNuclear chemistry
researchProduct

Opioid-induced or pain relief-reduced symptoms in advanced cancer patients?

2006

Abstract Background While opioids in increasing doses may produce adverse effects, the same adverse effects may be associated with poor pain control. Moreover, in the clinical setting symptomatic treatment and illness may balance the outcome of opioid titration. Some adverse effects may tend to disappear continuing the treatment in a long-term period. Aims The aim of this study was to monitor the effects of a rapid opioid titration combined with symptomatic treatment in patients with poor relief and to monitor these changes in the following period of 20 days. Methods A consecutive sample of 35 patients admitted to an acute Pain Relief and Palliative Care Unit were titrated with opioids, acc…

MaleWeaknessPalliative careConstipationNauseaOpioid-induced symptoms; pain relief; advanced cancer patients; longitudinal prospective studymedia_common.quotation_subjectPainpain reliefadvanced cancer patientlongitudinal prospective studyNeoplasmsmedicineHumansLongitudinal StudiesProspective StudiesAdverse effectmedia_commonbusiness.industryPalliative CareAppetiteMiddle AgedAnalgesics OpioidAnesthesiology and Pain MedicineOpioidPatient SatisfactionAnesthesiaEmergency MedicineVomitingFemalemedicine.symptomCancer painbusinessOpioid-induced symptommedicine.drug
researchProduct

The use of corticosteroids in home palliative care

2001

Evidence for the effectiveness of corticosteroids in palliative care is anecdotal, and more information is required. From January to December 1999 a total of 376 consecutive patients admitted to a home palliative care program were longitudinally surveyed. Patients who started a corticosteroid treatment after admission on the basis of common indications prescribed by their home care physicians were selected. Fifty patients were enrolled in the study. Dexametha-sone, in doses ranging from 4 to 16 mg, was the drug of choice. Corticosteroids were found to be effective in anorexia, weakness, headache, and nausea and vomiting. The reduction of symptom intensity was achieved in less than 3 days on…

MaleWeaknessPediatricsmedicine.medical_specialtyPalliative careNauseaLongitudinal epedemiological studyAnorexiaHome palliative careDexamethasoneStatistics NonparametricmedicineHumansCorticosteroidLongitudinal StudiesAdverse effectIntensive care medicineGlucocorticoidsNursing (all)2901 Nursing (miscellaneous)AgedAged 80 and overbusiness.industryPalliative CareTherapeutic effectMiddle Agedmedicine.diseaseHome Care ServicesBowel obstructionItalyOncologyVomitingFemalemedicine.symptombusiness
researchProduct

Oral chloral hydrate provides effective and safe sedation in paediatric magnetic resonance imaging.

1994

SUMMARY Sedation is routinely required for successful Magnetic Resonance imaging in infants and children. Five hundred and ninety-six paediatric patients (270 female and 326 male, age (mean±SD) 41±30 months and weight 14.8±6.5 kg) entered an open, non-comparative, prospective study to assess oral chloral hydrate sedation in a large and homogeneous paediatric population undergoing Magnetic Resonance imaging. Chloral hydrate syrup 70 mg/ml was administered 20–40 min prior to the procedure. Effective sedation was reached in 94.1% with a total dose (mean±SEM) of 68±1 mg/kg (range 20–170 mg/kg). Statistical analysis of sedation failures vs. successful examinations after the total dose showed sig…

Malemedicine.medical_specialtyAdolescentNauseamedicine.drug_classSedationPremedicationChloral hydrateConscious SedationAdministration OralOral administrationmedicineHumansPharmacology (medical)Chloral HydrateProspective StudiesProspective cohort studyChildPharmacologymedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryInfantMagnetic resonance imagingMagnetic Resonance ImagingSurgerySedativeAnesthesiaChild PreschoolData Interpretation StatisticalVomitingDrug EvaluationFemalemedicine.symptombusinessmedicine.drugJournal of clinical pharmacy and therapeutics
researchProduct

Évaluation de la prescription des antalgiques de palier II chez la personne âgée de 75 ans en médecine générale

2017

Although step-2 analgesics (S2A) are recommended when step-1 analgesics (S1A) are ineffective or in cases of moderate to severe pain, their efficacy varies. This study evaluated the place attributed by general practitioners (GPs) to S2A in the treatment of nociceptive pain in elderly persons (EP). Descriptive, transversal and declarative study conducted among GPs in Burgundy. In total, 115 GPs took part in the survey. Among these, 60.8% had at least one consultation/day for pain. After paracetamol, which was systematically preferred, 56.4% prescribed S2A for EP. The reasons for prescribing S2A included pain not relieved by S1A in 93% of cases, another medical treatment or not (42.6%), or th…

Malemedicine.medical_specialtyConstipationNauseaAnalgesic[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyDrug Prescriptionspersonne âgéeAmbulatory careGeneral PractitionersmedicineHumansPain ManagementMedical prescriptionAdverse effectBiological PsychiatryAgedAged 80 and overAnalgesics[SDV.MHEP.GEG] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologybusiness.industryChronic painmedicine.diseaseDrug Utilizationmédecine généraleNeuropsychology and Physiological PsychologyHealth Care Surveysantalgiques de palier IIVomitingPhysical therapyFemaleFranceNeurology (clinical)Chronic PainGeriatrics and Gerontologymedicine.symptombusinessGériatrie et Psychologie Neuropsychiatrie du Viellissement
researchProduct

Secondary aortoduodenal fistula.

2008

Aorto-duodenal fistulae (ADF) are the most frequent aorto-enteric fistulae (80%), presenting with upper gastrointestinal bleeding. We report the first case of a man with a secondary aorto-duodenal fistula presenting with a history of persistent occlusive syndrome. A 59-year old man who underwent an aortic-bi-femoral bypass 5 years ago, presented with dyspepsia and biliary vomiting. Computed tomography scan showed in the third duodenal segment the presence of inflammatory tissue with air bubbles between the duodenum and prosthesis, adherent to the duodenum. The patient was submitted to surgery, during which the prosthesis was detached from the duodenum, the intestine failed to close and a ga…

Malemedicine.medical_specialtyFistulaAortic DiseasesCase ReportAnastomosisDiagnosis DifferentialmedicineIntestinal FistulaHumansDuodenal Diseasesaortoenteric fistual surgery iatrogenic vascular surgerybusiness.industryGastroenterologyGeneral MedicineExplorative laparotomyMiddle Agedmedicine.diseaseSurgeryBlood Vessel ProsthesisProsthesis FailureBowel obstructionSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureDuodenumVomitingRadiologyUpper gastrointestinal bleedingmedicine.symptomComplicationbusinessWorld journal of gastroenterology
researchProduct

Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19

2021

Gender-related differences in COVID-19 clinical presentation, disease progression, and mortality have not been adequately explored. We analyzed the clinical profile, presentation, treatments, and outcomes of patients according to gender in the HOPE-COVID-19 International Registry. Among 2,798 enrolled patients, 1,111 were women (39.7%). Male patients had a higher prevalence of cardiovascular risk factors and more comorbidities at baseline. After propensity score matching, 876 men and 876 women were selected. Male patients more often reported fever, whereas female patients more often reported vomiting, diarrhea, and hyposmia/anosmia. Laboratory tests in men presented alterations consistent w…

Malemedicine.medical_specialtyLeadership and ManagementAnosmiaComorbidityAssessment and DiagnosisCohort Studies03 medical and health sciencesSex Factors0302 clinical medicineHyposmiaInternal medicinemedicineHumans030212 general & internal medicine030223 otorhinolaryngologyCare PlanningAgedAged 80 and overbusiness.industryHealth PolicyCOVID-19General MedicineMiddle Agedmedicine.diseaseComorbidityHospitalizationSystemic inflammatory response syndromeHeart Disease Risk FactorsPropensity score matchingDisease ProgressionVomitingFemaleFundamentals and skillsmedicine.symptomLymphocytopeniabusinessCohort studyJournal of Hospital Medicine
researchProduct

Conventional radiofrequency treatment in five patients with trigeminal neuralgia

2010

Introduction: In trigeminal neuralgia, when drug treatment proves ineffective, other management options must be considered. In this context, conventional radiofrequency of Gasser’s ganglion is a safe and effective alternative. Material and Methods: We describe 5 patients with long-evolving trigeminal neuralgia subjected to conventional radiofrequency according to the Sweet technique, with a follow-up of two years. Results: Pain relief was complete after two months in all cases. One patient suffered an unexpected episode of nausea, vomiting and foul odor sensation that subsided after three days of rest and drug treatment. Three patients described non-painful hypoesthesia in the region of the…

Malemedicine.medical_specialtyNauseaContext (language use)OdontologíaTrigeminal ganglionTrigeminal neuralgiaMedicineHumansGeneral DentistryAgedbusiness.industryHypoesthesiaMiddle AgedTrigeminal Neuralgiamedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryGanglionPulsed Radiofrequency TreatmentOrofacial Pain-TMJDmedicine.anatomical_structureOtorhinolaryngologyPulsed Radiofrequency TreatmentAnesthesiaUNESCO::CIENCIAS MÉDICASVomitingSurgeryFemaleResearch-Articlemedicine.symptombusiness
researchProduct

The course of symptom frequency and intensity in advanced cancer patients followed at home

2000

Four hundred consecutive patients who were referred to a home palliative care program were prospectively surveyed to estimate the prevalence and severity of common symptoms according to the changes in the performance status. Patients were admitted for the presence of different symptoms and psychosocial support. Common symptoms included in a standard form were rated for severity (absent 0, mild 1, moderate 2, severe 3) for each visit. Pain intensity was rated on a numerical scale (0-10). For each level of Karnofsky performance score (K), the frequency and the worse symptom intensity were recorded until patient's death. Data from 370 patients were analyzed. Pain was effectively controlled. In…

Malemedicine.medical_specialtyPalliative careNauseaEpidemiologyPopulationSymptomPainNeoplasmsInternal medicinemedicineHumansProspective StudiesProspective cohort studyeducationGeneral NursingNursing (all)2901 Nursing (miscellaneous)AgedPain MeasurementCancereducation.field_of_studyPerformance statusbiologybusiness.industryMiddle Agedbiology.organism_classificationHome Care ServicesDysphagiaAnesthesiology and Pain MedicineNeurologyPyrosisVomitingPhysical therapyKarnofsky performance statuPalliative careFemaleNeurology (clinical)medicine.symptombusiness
researchProduct